Debt Financings

Inuvo, Inc. incurred convertible notes of $3,333,333.33 with certain investors.

“the Company authorized the issuance of subordinated convertible notes to the Buyer, in the aggregate principal amount of $3,333,333.33”

INSEEGO CORP. incurred senior notes of $8 million in additional principal amount with an affiliate of Mubadala Capital at 9.0% maturing due 2029.

“(iii) $8 million in additional principal amount of the Company’s existing 9.0% Senior Secured Notes due 2029”

ITC Holdings Corp. incurred senior notes of $125,000,000 with institutional accredited investors at 5.71% per annum maturing January 14, 2046.

“$125,000,000 aggregate principal amount of its 5.71% Series B Senior Secured Notes due 2046”

ITC Holdings Corp. incurred senior notes of $125,000,000 with institutional accredited investors at 5.08% per annum maturing January 14, 2036.

“Michigan Electric Transmission Company, LLC (“METC”), an indirect wholly-owned subsidiary of ITC Holdings Corp. (the “Company”), issued $125,000,000 aggregate principal amount of its 5.08% Series A Senior Secured Notes due 2036”

Six Flags Entertainment Corporation/NEW incurred senior notes of $1,000,000,000 aggregate principal amount with U.S. Bank Trust Company, National Association at 8.625% per annum maturing January 15, 2032.

“The Notes were issued pursuant to an indenture, dated as of January 14, 2026 (the “Indenture”), by and among the Co-Issuers, the Guarantors (as defined below) and U.S. Bank Trust Company, National Association, as trustee. Interest and Maturity The Notes will accrue interest at a rate of 8.625% per annum, payable in cash semi-annually, in arrears, on January 15 and July 15 of each year, beginning on July 15, 2026.”

LXP Industrial Trust amended credit facility of $600.0 million senior unsecured revolving credit facility and $250.0 million unsecured term loan with KeyBank National Association at base rate plus a margin of 0.00% to 0.40% or daily SOFR or term SOFR plus 0.725% maturing January 31, 2030 for the Revolver and January 31, 2029 for the Term Loan.

“existing credit agreement, which we refer to as the Third Amended and Restated Credit Agreement, among the Trust, as borrower, each of the financial institutions initially a signatory thereto together with their assignees pursuant to Section 12.5 therein, and KeyBank National Association, or KeyBank, as agent. The Third Amended and Restated Credit Agreement amends and restates the Second Amended and Restated Credit Agreement, dated as of July 5, 2022, as the same was amended from time to time, which we refer to as the Existing Credit Agreement, among the Trust, as borrower, KeyBank, as agent, and each of the financial institutions initially a signatory thereto together with their assignees pursuant to Section 12.5 therein.”

Transportation & Logistics Systems, Inc. incurred loan of $75,000 with C/M Capital Master Fund, LP at 10% per annum maturing six months following the issuance date.

“On January 9, 2026, Transportation and Logistics Systems, Inc. (the " Company ", " we ", " us " or " our ") entered into an unsecured non-convertible promissory note (the " Note ") in the principal amount of $75,000, with interest at the rate of 10% per annum accruing and due at maturity six months following the issuance date, with C/M Capital Master Fund, LP (the " Lender ")”

Scorpius Holdings, Inc. incurred loan of $62,300.00 with institutional investor at 5.0% per annum maturing July 8, 2026.

“On January 8, 2026, the Company issued a non-convertible promissory note (the “Fourth Note”) in the principal amount of Sixty-two Thousand and Three Hundred Dollars ($62,300.00) to the Holder.”

Scorpius Holdings, Inc. incurred loan of $54,514.92 with institutional investor at 5.0% per annum maturing June 30, 2026.

“On December 30, 2025, the Company issued a non-convertible promissory note (the “Third Note”) in the principal amount of Fifty-four Thousand Five Hundred and Fourteen Dollars and Ninety-two Cents ($54,514.92) to the Holder.”

Scorpius Holdings, Inc. incurred loan of $78,350.00 with institutional investor at 5.0% per annum maturing June 17, 2026.

“On December 17, 2025, the Company issued a non-convertible promissory note (the “Second Note”) in the principal amount of Seventy-eight Thousand and Three Hundred and Fifty Dollars ($78,350.00) to the Holder.”

Scorpius Holdings, Inc. incurred loan of $44,374.85 with institutional investor at 5.0% per annum maturing June 16, 2026.

“On December 16, 2025, Scorpius Holdings, Inc. (the “Company”) issued a non-convertible promissory note (the “First Note”) in the principal amount of Forty-four Thousand Three Hundred Seventy-four Dollars and Eighty-five Cents ($44,374.85) to an institutional investor (the “Holder”).”

Clearway Energy, Inc. incurred senior notes of $600 million aggregate principal amount with CSC Delaware Trust Company at 5.750% maturing January 15, 2034.

“completed the sale of $600 million aggregate principal amount of 5.750% senior notes due 2034”

AI Era Corp. incurred convertible notes of $232,000 with Vanquish Funding Group Inc. at 10% per annum maturing October 15, 2026.

“the Company issued to the Lender a Convertible Promissory Note (the “Note”) in the principal amount of $232,000”

Clearway Energy LLC incurred senior notes of $600 million with CSC Delaware Trust Company at 5.750% maturing January 15, 2034.

“On January 13, 2026, Clearway Energy Operating LLC (“Clearway Operating”), a subsidiary of Clearway Energy LLC, completed the sale of $600 million aggregate principal amount of 5.750% senior notes due 2034”

AVITA Medical, Inc. incurred credit facility of up to $60 million with Perceptive Credit Holdings V, LP at greater of (x) the SOFR rate for such period and (y) 4.00% plus, in either case, maturing five-year senior secured credit facility.

“Credit Agreement provides for a five-year senior secured credit facility in an aggregate principal amount of up to $60 million”

GPGI, Inc. incurred senior notes of $1,000.0 million aggregate principal amount of 9.000% senior secured notes due 2029 with Husky at 9.000% maturing 2029.

“(iv) $1,000.0 million aggregate principal amount of 9.000% senior secured notes due 2029 (the “Existing Husky Notes")”

GPGI, Inc. incurred revolving credit of $50.0 million aggregate principal amount outstanding under Husky’s existing multi-currency super priority revolving cred with Husky at Not specified maturing Not specified.

“(iii) $50.0 million aggregate principal amount outstanding under Husky’s existing multi-currency super priority revolving credit facility (the “Existing Husky Revolver"”

GPGI, Inc. incurred term loan of $350.0 million aggregate principal amount drawn on the Closing Date under Husky’s existing U.S. dollar denominated delay with Husky at Not specified maturing Not specified.

“(ii) $350.0 million aggregate principal amount drawn on the Closing Date under Husky’s existing U.S. dollar denominated delayed draw term loan facility (the “Existing Delayed Draw Term Loan"”

GPGI, Inc. incurred term loan of $1,723.8 million aggregate principal amount outstanding under Husky’s existing U.S. dollar denominated term loan facilit with Husky at Not specified maturing Not specified.

“the Company assumed the indebtedness of Husky, including (i) $1,723.8 million aggregate principal amount outstanding under Husky’s existing U.S. dollar denominated term loan facility (the “Existing Husky Term Loan")”

HPS Corporate Lending Fund incurred senior notes of $400,000,000 with U.S. Bank Trust Company, National Association at 5.650% maturing April 2, 2031.

“On January 13, 2026, HPS Corporate Lending Fund (the “ Fund ”) and U.S. Bank Trust Company, National Association (the “ Trustee ”) entered into (i) a Ninth Supplemental Indenture (the “ Ninth Supplemental Indenture ”) relating to the Fund’s issuance of $350,000,000 in aggregate principal amount of its 5.150% notes due 2029 (the “ 2029 Notes ”) and (ii) a Tenth Supplemental Indenture (the “ Tenth Supplemental Indenture ”) relating to the Fund’s issuance of $400,000,000 in aggregate principal amount of its 5.650% notes due 2031 (the “ 2031 Notes ””

HPS Corporate Lending Fund incurred senior notes of $350,000,000 with U.S. Bank Trust Company, National Association at 5.150% maturing April 2, 2029.

“On January 13, 2026, HPS Corporate Lending Fund (the “ Fund ”) and U.S. Bank Trust Company, National Association (the “ Trustee ”) entered into (i) a Ninth Supplemental Indenture (the “ Ninth Supplemental Indenture ”) relating to the Fund’s issuance of $350,000,000 in aggregate principal amount of its 5.150% notes due 2029 (the “ 2029 Notes ”)”

Resolute Holdings Management, Inc. incurred revolving credit of $50.0 million.

“(iii) $50.0 million aggregate principal amount outstanding under Husky’s existing multi-currency super priority revolving credit facility”

Resolute Holdings Management, Inc. incurred term loan of $350.0 million.

“(ii) $350.0 million aggregate principal amount drawn on the Closing Date under Husky’s existing U.S. dollar denominated delayed draw term loan facility”

Resolute Holdings Management, Inc. incurred term loan of $1,723.8 million.

“CompoSecure assumed the indebtedness of Husky, including (i) $1,723.8 million aggregate principal amount outstanding under Husky’s existing U.S. dollar denominated term loan facility”

Resolute Holdings Management, Inc. incurred senior notes of $1,000.0 million at 9.000% maturing 2029.

“(iv) $1,000.0 million aggregate principal amount of 9.000% senior secured notes due 2029”

TANGER PROPERTIES LTD PARTNERSHIP /NC/ incurred convertible notes of $250,000,000 aggregate principal amount with BofA Securities, Inc. at 2.375% per year, payable semi-annually in arrears on January 15 and July 15 maturing January 15, 2031.

“On January 12, 2026, Tanger Properties Limited Partnership (the “Operating Partnership”), the operating partnership of Tanger Inc. (the “Company”), issued $250 million aggregate principal amount of its 2.375% Exchangeable Senior Notes due 2031 (the “Notes”), which included $30 million principal amount of Notes purchased pursuant to the full exercise of the option granted to the Initial Purchasers (as defined below) pursuant to the Purchase Agreement (as defined below).”

CVRx, Inc. amended credit facility of $50 million with Innovatus Life Sciences Fund I, LP at floating rate per annum equal to the sum of (i) the greater of (A) the prime rat maturing May 9, 2031.

“Pursuant to the Amendment, (a) the terms loans available to the Company are increased by $50 million, to an aggregate principal amount of up to $100 million”

CVRx, Inc. incurred term loan of $10 million with Innovatus Life Sciences Fund I, LP at prime rate plus 2.65% maturing May 9, 2031.

“revenue exceeds $100 million. The term loans continue to be secured by substantially all of the Company’s assets. Also on the Closing Date, the Company borrowed an additional $10 million under the Loan Agreement, bringing the total outstanding principal amount of term loans to $60 million. The Company has the option to draw (i) $15 million between June 1, 2027”

Jaguar Health, Inc. incurred loan of $350,000 aggregate principal amount with two accredited investors at 6% per annum maturing one month after issuance.

“On January 6, 2026 (the “Execution Date”), Jaguar Health, Inc. (the “Company”) entered into securities purchase agreements (the “Securities Purchase Agreements”) with two accredited investors (each, an “Investor”), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes (collectively, the “Notes”) to such Investors.”

Jaguar Health, Inc. incurred senior notes of $350,000 aggregate principal amount at 6% per annum maturing one month after issuance.

“On January 5, 2026 (the “Execution Date”), Jaguar Health, Inc. (the “Company”) entered into securities purchase agreements (the “Securities Purchase Agreements”) with two accredited investors (each, an “Investor”), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes (collectively, the “Notes”) to such Investors.”

Jaguar Health, Inc. incurred senior notes of $350,000 at 6% per annum maturing one month after issuance.

“On January 6, 2026 (the “Execution Date”), Jaguar Health, Inc. (the “Company”) entered into securities purchase agreements (the “Securities Purchase Agreements”) with two accredited investors (each, an “Investor”), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes (collectively, the “Notes”) to such Investors.”

Optimum Communications, Inc. incurred term loan of $1,100 million with JPMorgan Chase Bank, N.A. at a fixed rate per annum equal to 9.000% maturing November 25, 2028.

“The A&R UnSub Credit Agreement provides for, among other things, an incremental term loan commitment in an aggregate principal amount of $1,100 million. The loans made pursuant to the incremental term loan commitment (the “UnSub Incremental Term Loan”) have the same terms as the initial term loans extended pursuant to the Credit Agreement, dated as of November 25, 2025, among, inter alios, CSC Optimum, Cablevision Litchfield, the guarantors party thereto, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative and collateral agent and will (i) mature on November 25, 2028, (ii) accrue interest at a fixed rate per annum equal to 9.000% and (iii) not amortize.”

SelectQuote, Inc. incurred revolving credit of $90 million senior secured revolving credit facility with PLC Agent LLC, as administrative agent, UMB Bank, N.A., as lender and revolver agent at SOFR (subject to a floor of 3.00%) plus 4.00%.

“The Credit Agreement provides for (i) a $325 million senior secured term loan (the “ Term Loan ”) and (ii) a $90 million senior secured revolving credit facility (the “ Revolving Credit Facility ” and, together with the Term Loan, the “ Senior Secured Credit Facility ”).”

SelectQuote, Inc. incurred term loan of $325 million senior secured term loan with PLC Agent LLC, as administrative agent, UMB Bank, N.A., as lender and revolver agent at SOFR (subject to a floor of 3.00%) plus 6.50%.

“On January 8, 2026 (the “ Closing Date ”), SelectQuote, Inc. (the “ Company ”) entered into a credit agreement (the “ Credit Agreement ” or “ Agreement ”) with PLC Agent LLC, as administrative agent, UMB Bank, N.A. (“ UMB ”), as lender and revolver agent, and the other lenders party thereto. The Credit Agreement provides for (i) a $325 million senior secured term loan (the “ Term Loan ”) and (ii) a $90 million senior secured revolving credit facility”

Sky Harbour Group Corp incurred credit facility of approximately $13 million with JPMorgan Chase Bank, N.A., as administrative agent.

“SH Capital II drew funds of approximately $13 million under the Credit Agreement in order to reimburse the Company for prior advances”

Fidelity Private Credit Fund amended credit facility with Citibank, N.A. at reduction of the applicable margin (a) prior to the commitment termination date, maturing extension of the maturity date from December 2029 to December 2030.

“The First Amendment provides for, among other things, (i) an extension of the reinvestment period from December 2027 to December 2028, (ii) an extension of the maturity date from December 2029 to December 2030, and (iii) a reduction of the applicable margin (a) prior to the commitment termination date, from 2.30% per annum to 1.95% per annum, and (b) on and after the commitment termination date, from 2.80% per annum to 2.45% per annum.”

INSPIRE VETERINARY PARTNERS, INC. incurred convertible notes of up to an aggregate of $1,626,000 principal amount of convertible promissory notes with Manetto Hill Fund Series I LLC.

“On January 6, 2026, effective as of December 31, 2025, Inspire Veterinary Partners, Inc. (the "Company") entered into a securities purchase agreement with Manetto Hill Fund Series I LLC, a Delaware limited liability company ("Manetto") whereby the Company may issue up to an aggregate of $1,626,000 principal amount of convertible promissory notes in one or more closings, subject to the terms and conditions set forth therein.”

INSPIRE VETERINARY PARTNERS, INC. incurred convertible notes of $975,000 with Manetto Hill Fund Series I LLC at 10% per annum maturing December 31, 2026.

“On January 6, 2026, effective as of December 31, 2025, the Company issued to a secured convertible promissory note in the principal amount of $975,000 for a purchase price of $750,000 (the "Note").”

RenX Enterprises Corp. incurred loan of $5,000,000 with an institutional investor at 13.50% per annum maturing December 1, 2028.

“● LV Peninsula issued a conditional promissory note, dated January 6, 2026 (the “New Note”), in the principal amount of $5,000,000 to the Lender”

Calumet, Inc. /DE incurred senior notes of $405.0 million at 9.75% maturing February 15, 2031.

“On January 12, 2026, Calumet Specialty Products Partners, L.P. (the “Partnership”) and Calumet Finance Corp. (“Finance Corp.” and, together with the Partnership, the “Issuers”), each a subsidiary of Calumet, Inc. (the “Company”), issued $405.0 million aggregate principal amount of a new series of the Issuers’ 9.75% Senior Notes due 2031 (the “Notes”) in a private placement”

Augusta SpinCo Corp incurred term loan of up to $4 billion with Barclays Bank PLC (as administrative agent) at alternate base rate or Term SOFR rate, in each case, plus an applicable margin maturing Tranche 1 matures 364 days after the Closing Date and Tranche 2 matures on the second anniversary of the Closing Date.

“and the Merger Agreement will be consummated is referred to as the “Acquisition Effective Date”. The Credit Agreement provides the Company with the ability to borrow up to $4 billion on an unsecured basis to finance a cash distribution to BD in connection with the transaction (the “BD Special Cash Payment”) and related fees and expenses, and any proceeds in”

DYNATRONICS CORP reported a default on credit facility with Gibraltar Business Capital, LLC.

“Trigger one or more events of default under the Company's Loan and Security Agreement dated as of August 1, 2023 with Gibraltar Business Capital, LLC.”

INTUIT INC. incurred revolving credit of $2.2 billion with JPMorgan Chase Bank, N.A., as administrative agent at alternate base rate plus a margin that ranges from 0.000% to 0.125% or term Secu maturing January 9, 2031.

“The Credit Agreement provides for a $2.2 billion unsecured revolving credit facility (the “Facility”) that expires on January 9, 2031.”

WILLIS TOWERS WATSON PLC incurred term loan of $775,000,000 delayed draw term loan facility with JPMorgan Chase Bank, N.A. at Term SOFR rate plus an applicable margin of 0.625% to 1.250% maturing the earlier of (i) the third anniversary of the initial borrowing of loans under the Credit Facility and (ii) the third anniversary of the date that is two mont.

“On January 7, 2026, Willis Towers Watson Public Limited Company (“WTW”), together with its wholly owned subsidiary, Trinity Acquisition plc, a limited company formed under the laws of England and Wales (“TA”) and TA’s indirect wholly owned subsidiary, Willis North America Inc., a Delaware corporation (“WNA” and together with TA, the “Borrowers”) entered into a $775,000,000 delayed draw term loan facility (the “Credit Facility”).”

PEDEVCO CORP incurred revolving credit of $6 million with Citibank, N.A..

“On January 8, 2026, the Company borrowed an additional $6 million under the A&R Credit Agreement (the " Draw Down ").”

Western Union CO incurred term loan of $800,000,000 with Bank of America, N.A. at Term SOFR Rate plus an interest rate margin determined on a sliding scale from 1 maturing the third anniversary of the initial funding date.

“On January 9, 2026 (the “Closing Date”), The Western Union Company (“Western Union”) entered into a delayed draw term loan credit agreement (the “Term Loan Agreement”) providing for an unsecured term loan facility in an aggregate amount of $800,000,000 with a syndicate of lenders, State Bank of India, New York Branch and Wells Fargo Bank, National Association, as Syndication Agents, Bank of Baroda, New York Branch, Bank of China Limited, Chicago Branch and U.S. Bank National Association, as Documentation Agents, and Bank of America, N.A., as Administrative Agent for the banks thereunder.”

MSP Recovery, Inc. reported a default on convertible notes with YA II PN, LTD.

“the expiration of the Primary Market Period on January 6, 2026 constituted a technical Event of Default under the Notes”

NKGen Biotech, Inc. incurred loan of $25,840,106 with AlpineBrook Capital GP I Limited at 12% per annum maturing initially on the date falling two months after issuance, subject to extension at the Lender’s discretion.

“On January 5, 2026, NKGen Biotech, Inc., a Delaware corporation (the “ Company ”), and NKGen Operating Biotech, Inc., a Delaware corporation (the “ Company Sub ,” and together with the Company, the “ Borrowers ”), entered into a secured promissory note (the “ Note ”) with AlpineBrook Capital GP I Limited (the “ Lender ”), in the original principal amount of $25,840,106, bearing interest at 12% per annum and maturing initially on the date falling two months after issuance, subject to extension at the Lender’s discretion.”

ProFrac Holding Corp. incurred senior notes of $25 million aggregate principal amount with Beal Bank USA at Senior Secured Floating Rate Notes maturing due 2029.

“On January 7, 2026, ProFrac Holdings II, LLC, a Texas limited liability company (" ProFrac Holdings II ") and an indirect wholly-owned subsidiary of ProFrac Holding Corp. (the " Company " or " ProFrac "), issued $25 million aggregate principal amount of its Senior Secured Floating Rate Notes due 2029 (the " New Notes ") to Beal Bank USA in a private placement.”

Eureka Acquisition Corp incurred loan of up to $300,000 with Hercules Capital Management Corp at no interest maturing upon the earlier to occur of the Maturity Date.

“On January 6, 2026, the Company issued an unsecured promissory note (the “ Sponsor Note ”) in the principal amount of up to $300,000 to the Sponsor.”